volume 99, issue 2, P222-225 1997
DOI: 10.1542/peds.99.2.222
View full text
|
|
Share
M. Ruiz-Moreno, P. Fernandez, A. Leal, J. Bartolome, I. Castillo, H. Oliva, V. Carreno

Abstract: IFN-beta seems to be an effective retreatment therapy for children with chronic hepatitis B who are nonresponders to a first IFN-alpha cycle; however, a controlled study should be performed to confirm these results.